AVITA Medical, Inc. (RCEL)
$10.35+$0.03 (+0.29%) Today
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 10 | 47,200 | $197K |
| Grant or award | 19 | 357,388 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
28 Form 4 filings on record, the earliest from Dec 5, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David D. O'Toole - Officer | Open-market purchase | Common Stock | 2,000 | $3.97 | $8K | |
| David D. O'Toole - Officer | Grant or award | Common Stock | 2,000 | $3.97 | $8K | |
| Joseph Fralin Woody | Open-market purchase | Common Stock | 5,200 | $4.00 | $21K | |
| Joseph Fralin Woody | Open-market purchase | Common Stock | 5,000 | $4.20 | $21K | |
| Joseph Fralin Woody | Open-market purchase | Common Stock | 5,000 | $4.18 | $21K | |
| Joseph Fralin Woody | Open-market purchase | Common Stock | 5,000 | $4.10 | $20K | |
| Joseph Fralin Woody | Open-market purchase | Common Stock | 5,000 | $4.09 | $20K | |
| Robert McNamara | Grant or award | Common Stock | 22,214 | - | - | |
| Robert McNamara | Grant or award | Stock Options (Right to Buy) | 16,133 | $0.00 | - | |
| Joseph Fralin Woody | Grant or award | Common Stock | 40,547 | - | - | |
| Joseph Fralin Woody | Grant or award | Common Stock | 22,214 | - | - | |
| Joseph Fralin Woody | Grant or award | Stock Options (Right to Buy) | 29,446 | $0.00 | - | |
| Joseph Fralin Woody | Grant or award | Stock Options (Right to Buy) | 16,133 | $0.00 | - | |
 Michael E. Tarnoff | Grant or award | Common Stock | 26,250 | - | - | |
| Michael E. Tarnoff | Grant or award | Common Stock | 22,214 | - | - | |
| Michael E. Tarnoff | Grant or award | Stock Options (Right to Buy) | 19,063 | $0.00 | - | |
| Michael E. Tarnoff | Grant or award | Stock Options (Right to Buy) | 16,133 | $0.00 | - | |
| Jeremy Curnock Cook | Grant or award | Common Stock | 22,214 | - | - | |
| Jeremy Curnock Cook | Grant or award | Stock Options (Right to Buy) | 16,133 | $0.00 | - | |
| Suzanne Crowe | Grant or award | Common Stock | 22,214 | - | - | |
| Suzanne Crowe | Grant or award | Stock Options (Right to Buy) | 16,133 | $0.00 | - | |
 Jan Stern Reed | Grant or award | Common Stock | 22,214 | - | - | |
| Jan Stern Reed | Grant or award | Stock Options (Right to Buy) | 16,133 | $0.00 | - | |
| Joseph Fralin Woody | Open-market purchase | Common Stock | 5,000 | $4.34 | $22K | |
| Joseph Fralin Woody | Open-market purchase | Common Stock | 5,000 | $4.26 | $21K | |
| Joseph Fralin Woody | Open-market purchase | Common Stock | 5,000 | $4.18 | $21K | |
| Joseph Fralin Woody | Open-market purchase | Common Stock | 5,000 | $4.21 | $21K | |
| David D. O'Toole - Officer | Grant or award | Common Stock | 5,000 | $3.05 | $15K | |
| Cary Guy Vance - Officer | Grant or award | Common Stock | 5,000 | $3.05 | $15K | |
| David D. O'Toole - Officer | Open-market purchase | Common Stock | 2,000 | $4.26 | $9K | |
| David D. O'Toole - Officer | Open-market purchase | Common Stock | 2,000 | $4.24 | $8K | |
| David D. O'Toole - Officer | Open-market purchase | Common Stock | 1,800 | $4.78 | $9K | |
| David D. O'Toole - Officer | Open-market purchase | Common Stock | 3,000 | $4.15 | $12K | |
| David D. O'Toole - Officer | Grant or award | Common Stock | 105,470 | - | - | |
| David D. O'Toole - Officer | Grant or award | Stock Options (Right to Buy) | 155,510 | $0.00 | - | |
| Nicole Kelsey - Officer | Grant or award | Common Stock | 98,390 | - | - | |
| Nicole Kelsey - Officer | Grant or award | Stock Options (Right to Buy) | 145,060 | $0.00 | - | |
| Robert McNamara | Open-market purchase | Common Stock | 10,000 | $4.50 | $45K | |
| David D. O'Toole - Officer | Open-market purchase | Common Stock | 2,000 | $4.52 | $9K | |
| Robert McNamara | Open-market purchase | Common Stock | 10,000 | $5.00 | $50K | |
| David D. O'Toole - Officer | Open-market purchase | Common Stock | 2,000 | $4.81 | $10K | |
| James Corbett - Officer | Grant or award | Stock Options (Right to Buy) | 520,000 | $0.00 | - | |
| Jeremy Curnock Cook | Grant or award | Common Stock | 10,022 | - | - | |
| Jeremy Curnock Cook | Grant or award | Stock Options (Right to Buy) | 4,295 | $0.00 | - | |
| Jan Stern Reed | Grant or award | Common Stock | 10,022 | - | - | |
| Jan Stern Reed | Grant or award | Stock Options (Right to Buy) | 4,295 | $0.00 | - | |
| David D. O'Toole - Officer | Grant or award | Common Stock | 785 | $7.83 | $6K | |
| David D. O'Toole - Officer | Open-market purchase | Common Stock | 475 | $12.53 | $6K | |
| David D. O'Toole - Officer | Open-market purchase | Common Stock | 500 | $12.40 | $6K |
AVITA Medical, Inc. (RCEL) had 14 insider filings in the last 90 days, with the most recent on 2026-08-24. The full record for RCEL runs to 28 Form 4 filings, the earliest from 2024-12-05. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
10 insider purchases of RCEL were filed in the last 90 days, totaling $197K.
No insider sales of RCEL were filed in the last 90 days.
This page tracks RCEL Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add RCEL to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
